Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies

Bibliography

• Feng SS, Mu L, Win KY, et al. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Curr Med Chem 2004;11(4):413-24
   PubMed Web of Science ®Google Scholar
• Fisher B. Biological and clinical considerations regarding use of surgery and chemotherapy in treatment of primary breast-cancer. Cancer 1977;40(1):574-87
   PubMed Web of Science ®Google Scholar
• Coleman CN, Beard CJ, Kantoff PW, et al. Rate of relapse following treatment for localized prostate-cancer – a critical analysis of retrospective reports. Int J Radiat Oncol Biol Phys 1994;28(1):303-13
   PubMed Web of Science ®Google Scholar
• O'Driscol CM. Anatomy and physiology of the lymphatics. In: Lymphatic transport of drugs, Charman WN, Stella VJ (Eds.), CRC Press, Boca Raton, Florida, USA 1996.p.1-37
   Google Scholar
• Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2(8):563-72
   PubMed Web of Science ®Google Scholar
• McCarter MD, Clarke JH, Harken AH. Lymphangiogenesis is pivotal to the trials of a successful cancer metastasis. Surgery 2004;135(2):121-4
   PubMed Web of Science ®Google Scholar
• Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004;4(6):448-56
   PubMed Web of Science ®Google Scholar
• Sleeman J. The lymph node as a bridgehead in the metastatic dissemination of tumors. Rec Results Cancer Res 2000;157:55-81
   PubMedGoogle Scholar
• Sleeman JP. The relationship between tumors and the lymphatics: what more is there to know? Lymphology 2006;39(2):62-8
   PubMed Web of Science ®Google Scholar
• Oussoren C, Storm G. Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev 2001;50(1-2):143-56
   PubMed Web of Science ®Google Scholar
• Barenholz Y, Amselem S, Goren D, et al. Stability of liposomal doxorubicin formulations – problems and prospects. Med Res Rev 1993;13(4):449-91
   PubMed Web of Science ®Google Scholar
• Fujimoto Y, Okuhata Y, Tyngi S, et al. Magnetic resonance lymphography of profundus lymph nodes with liposomal gadolinium-diethylenetriamine pentaacetic acid. Biol Pharmacol Bull 2000;23(1):97-100
   PubMed Web of Science ®Google Scholar
• Torchilin VP, Trubetskoy VS, Milshteyn AM, et al. Targeted delivery of diagnostic agents by surface-modified liposomes. J Control Release 1994;28(1-3):45-58
   Web of Science ®Google Scholar
• Trubetskoy VS, Cannillo JA, Milshtein A, et al. Controlled delivery of gd-contaning liposomes to lymph-nodes - surface modification may enhance MRI contrast properties. Magn Reson Imaging 1995;13(1):31-7
   PubMed Web of Science ®Google Scholar
• Kim CK, Choi YJ, Lim SJ, et al. Lymph node targeting and pharmacokinetics of [3H]methotrexate-encapsulated neutral large unilamellar vesicles and immunoliposomes. Int J Pharm 1993;98(1-3):9-18
   Google Scholar
• Kim CK, Han JH. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats. J Microencapsul 1995;12(4):437-46
   PubMed Web of Science ®Google Scholar
• Kim CK, Lee MK, Han JH, et al. Pharmacokinetics and tissue distribution of methotrexate after intravenous-injection of differently charged liposome-entrapped methotrexate to rats. Int J Pharm 1994;108(1):21-9
   Web of Science ®Google Scholar
• Tokunaga Y, Iwasa T, Fujisaki J, et al. Liposomal sustained-release delivery systems for intravenous-injection.2. Design of liposome carriers and blood disposition of lipophilic mitomycin-c prodrug-bearing liposomes. Chem Pharm Bull 1988;36(9):3557-64
   PubMed Web of Science ®Google Scholar
• Parker RJ, Hartman KD, Sieber SM. Lymphatic absorption and tissue disposition of liposome-entrapped [adriamycin-c-14 following intraperitoneal administration to rats. Cancer Res 1981;41(4):1311-7
   PubMed Web of Science ®Google Scholar
• Parker RJ, Priester ER, Sieber SM. Effect of route administration and liposome entrapment on the metabolism and disposition of adriamycin in the rat. Drug Metab Dispos 1982;10(5):499-504
   PubMed Web of Science ®Google Scholar
• Akamo Y, Mizuno I, Yotsuyanagi T, et al. Chemotherapy targeting regional lymph-nodes by gastric submucosal injection of liposomal adriamycin in patients with gastric-carcinoma. Jpn J Cancer Res 1994;85(6):652-8
   PubMedGoogle Scholar
• Khato J, Priester ER, Sieber SM. Enhanced lymph-node uptake of melphalan following liposomal entrapment and effects on lymph-node metastasis in rats. Cancer Treat Rep 1982;66(3):517-27
   PubMedGoogle Scholar
• Khato J, Delcampo AA, Sieber SM. Carrier activity of sonicated small liposomes containing melphalan to regional lymph-nodes of rats. Pharmacology 1983;26(4):230-40
   PubMed Web of Science ®Google Scholar
• Takakura Y, Matsumoto S, Hashida M, et al. Enhanced lymphatic delivery of mitomycin-c conjugated with dextran. Cancer Res 1984;44(6):2505-10
   PubMed Web of Science ®Google Scholar
• Jeong YI, Kim ST, Jin SG, et al. Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation. J Pharm Sci 2008;97(3):1268-76
   PubMed Web of Science ®Google Scholar
• Cai S, Xie YM, Bagby TR, et al. Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate. J Surg Res 2008;147(2):247-52
   PubMed Web of Science ®Google Scholar
• Liu J, Wong HL, Moselhy J, et al. Targeting colloidal particulates to thoracic lymph nodes. Lung Cancer 2006;51(3):377-86
   PubMed Web of Science ®Google Scholar
• Liggins RT, D'Amours S, Demetrick JS, et al. Paclitaxel loaded poly(L-lactic acid) microspheres for the prevention of intraperitoneal carcinomatosis after a surgical repair and tumor cell spill. Biomaterials 2000;21(19):1959-69
   PubMed Web of Science ®Google Scholar
• Lu HX, Li B, Kang Y, et al. Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting. Cancer Chemother Pharmacol 2007;59(2):175-81
   PubMed Web of Science ®Google Scholar
• Maincent P. Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats. Pharm Res 1992;9(12):1534-9
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Kawamoto S, Sakai Y, et al. Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J Natl Cancer Inst 2004;96(9):703-8
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Kawamoto S, Bernardo M, et al. Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J Control Release 2006;111(3):343-51
   PubMed Web of Science ®Google Scholar
• Hawley AE, Illum L, Davis SS. Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm Res 1997;14(5):657-61
   PubMed Web of Science ®Google Scholar
• Kato T, Prevo R, Steers G, et al. A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity. Br J Cancer 2005;93(10):1168-74
   PubMed Web of Science ®Google Scholar
• Jackson DG. Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis. Apmis 2004;112(7-8):526-38
   PubMed Web of Science ®Google Scholar
• Fujimoto A, Ishikawa Y, Akishima-Fukasawa Y, et al. Significance of lymphatic invasion on regional lymph node metastasis in early gastric cancer using LYVE-1 immunohistochemical analysis. Am J Clin Pathol 2007;127(1):82-8
   PubMed Web of Science ®Google Scholar
• McElroy M, Hayashi K, Garmy-Susini B, et al. Fluorescent LYVE-1 antibody to image dynamically lymphatic trafficking of cancer cells in vivo. J Surg Res 2009;151(1):68-73
   PubMed Web of Science ®Google Scholar
• Kitamura K, Takahashi T, Kotani T, et al. Local-administration of monoclonal antibody-drug conjugate – a new strategy to reduce the local recurrence of colorectal-cancer. Cancer Res 1992;52(22):6323-8
   PubMed Web of Science ®Google Scholar
• Kitamura K, Takahashi T, Noguchi A, et al. Pharmacokinetic analysis of the monoclonal-antibody A7-neocarzinostatin conjugate administered to nude-mice. Tohoku J Exp Med 1991;164(3):203-11
   PubMed Web of Science ®Google Scholar